Quantum BioPharma (XCNQ:QNTM) Other Income (Expense) : C$-6.64 Mil (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Quantum BioPharma Other Income (Expense)?

Quantum BioPharma's other income expense for the Quantum BioPharma's pretax income for the three months ended in Mar. 2025 was C$-7.28 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2025 was C$-6.64 Mil.

Quantum BioPharma Other Income (Expense) Historical Data

The historical data trend for Quantum BioPharma's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum BioPharma Other Income (Expense) Chart

Quantum BioPharma Annual Data

Trend

Aug15

Aug16

Aug17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Income (Expense)

Get a 7-Day Free Trial

3.05

-0.16

-1.25

0.74

0.63

Quantum BioPharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Income (Expense)	Get a 7-Day Free Trial															-	0.03	-0.13	0.73	-7.28

Quantum BioPharma Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-6.64 Mil.

Quantum BioPharma (XCNQ:QNTM) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Quantum BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Quantum BioPharma Ltd (XCNQ:QNTM) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

QNTM:USA 0K91:Germany

Address

55 University Avenue, Suite 1003, Toronto, ON, CAN, M5J 2H7

Website

https://www.fsdpharma.com

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.